Neuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease.
Recent human trials of treatments for Alzheimer's disease (AD) have been largely unsuccessful, raising the idea that treatment may need to be started earlier in the disease, well before cognitive symptoms appear. An early marker of AD pathology is therefore needed and it is debated as to whethe...
Main Authors: | Amanda L Wright, Raphael Zinn, Barbara Hohensinn, Lyndsey M Konen, Sarah B Beynon, Richard P Tan, Ian A Clark, Andrea Abdipranoto, Bryce Vissel |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23560052/pdf/?tool=EBI |
Similar Items
-
Chronic apocynin treatment attenuates beta amyloid plaque size and microglial number in hAPP(751)(SL) mice.
by: Melinda E Lull, et al.
Published: (2011-01-01) -
Serum Corticosterone and Insulin Resistance as Early Biomarkers in the hAPP23 Overexpressing Mouse Model of Alzheimer’s Disease
by: Jhana O. Hendrickx, et al.
Published: (2021-06-01) -
Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice
by: Johannes Steffen, et al.
Published: (2017-06-01) -
Delta-secretase triggers Alzheimer’s disease pathologies in wild-type hAPP/hMAPT double transgenic mice
by: Zhourui Wu, et al.
Published: (2020-12-01) -
The effect of learning stimulation on functional and pathological deficits in hAPP transgenic mice
by: Jhen-Ling Chen, et al.
Published: (2018)